Integra LifeSciences Trims FY22 Adj. EPS, Revenue Outlook; Q2 Results Top Estimates

RTTNews | 1032 days ago
Integra LifeSciences Trims FY22 Adj. EPS, Revenue Outlook; Q2 Results Top Estimates

(RTTNews) - While reporting financial results for the second quarter on Wednesday, medical technology company Integra LifeSciences Holdings Corp. (IART) trimmed its adjusted earnings and revenue guidance for the full-year 2022. The company also issued outlook for the third quarter.

For fiscal 2022, the company continues to project adjusted earnings in a range of $3.21 to $3.29 per share on revenues between $1.557 billion and $1.575 billion, with organic revenue growth of 4.0 to 5.2 percent, based on better than expected first half performance.

Previously, the company expected adjusted earnings in a range of $3.27 to $3.35 per share on revenues between $1.58 billion and $1.60 billion, with organic revenue growth of 3.8 to 5.2 percent.

On average, 11 analysts polled by Thomson Reuters expect the company to report earnings of $3.31 per share on revenues of $1.59 billion for the year. Analysts' estimates typically exclude special items.

For the third quarter, the company expects adjusted earnings in a range of $0.78 to $0.82 per share on revenues between $383 million and $391 million, with organic revenue growth of 2.6 to 4.8 percent.

The Street is looking for earnings of $0.84 per share on revenues of $398.66 million for the quarter.

For the second quarter, the Company reported net income of $44.79 million or $0.54 per share, up from $35.07 million or $0.41 per share in the prior-year quarter. Excluding items, adjusted earnings for the quarter was $0.82 per share, compared to $0.79 per share in the year-ago quarter.

Total revenues for the quarter increased 2.0 percent to $397.82 million from $389.99 million in the same quarter last year. Organic revenue grew 4.8 percent.

Analysts expected the company to report earnings of $0.80 per share on revenues of $395.27 million for the quarter.

For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com

read more
Integra LifeSciences To Acquire Acclarent For $275 Mln Cash

Integra LifeSciences To Acquire Acclarent For $275 Mln Cash

Medical technology firm Integra LifeSciences Holdings Corp. (IART) announced Wednesday that it has entered into a definitive agreement to acquire Acclarent, Inc. from Ethicon, Inc., a Johnson & Johnson MedTech company, for $275 million in cash at closing. This is subject to customary purchase price adjustments, and an additional $5 million upon the achievement of certain regulatory milestones.
RTTNews | 528 days ago
Euro Slips On Trump's Tariff Proposal

Euro Slips On Trump's Tariff Proposal

The euro fell against its major counterparts on Friday, as President Donald Trump proposed tariffs on imports from the European Union starting on June 1.
RTTNews | 18h 16min ago
Swiss Market Ends Weak On Tariff Concerns

Swiss Market Ends Weak On Tariff Concerns

After opening on a positive note and staying above the flat line till about an hour past noon, the Switzerland market tumbled on Friday, hurt by U.S. President Donald Trump's threat that imports from the European Union will face 50% tariffs from June 1st.
RTTNews | 19h 8min ago
European Stocks Closed Weak On Trump's Fresh Tariff Threat

European Stocks Closed Weak On Trump's Fresh Tariff Threat

European stocks closed on a weak note on Friday despite staging a fairly strong recovery past mid afternoon. After staying modestly higher till noon, the major European markets tumbled after U.S. President Donald Trump threatened to impose 50% tariffs on imports from the European Union from June 1st.
RTTNews | 19h 24min ago
TSX Recovers After Early Setback; Materials Stocks Move Higher

TSX Recovers After Early Setback; Materials Stocks Move Higher

After a weak start and a subsequent drop to lower levels, the Canadian market recovered well and is down just marginally a little past noon on Friday. The early setback was due to U.S. President Donald Trump's threat that 50% tariffs will be imposed on imports from the European Union beginning June 1st.
RTTNews | 20h 32min ago
U.S. New Home Sales Spike From Downwardly Revised Level In April

U.S. New Home Sales Spike From Downwardly Revised Level In April

The Commerce Department released a report on Friday showing new home sales in the U.S. in the month of April spiked compared to a significantly downwardly revised level in March. The report said new home sales soared by 10.9 percent to an annual rate of 743,000 in April after jumping by 2.6 percent to a downwardly revised rate of 670,000 in March.
RTTNews | 22h 6min ago
Germany Logs Stronger Growth On Tariff Threats

Germany Logs Stronger Growth On Tariff Threats

The German economy grew at a stronger-than-estimated pace in the first quarter as higher tariff threats by the U.S. administration led to the frontloading of orders for the country's goods, lifting exports and industrial production. Gross domestic product grew 0.4 percent, which was double the initial estimate of 0.2 percent, a detailed report from Destatis revealed on Friday.
RTTNews | 23h 12min ago
Bay Street Likely To Open On Negative Note On Tariff Concerns

Bay Street Likely To Open On Negative Note On Tariff Concerns

Canadian shares look headed for a weak start Friday morning as tariff concerns resurfaced after U.S. President Donald Trump threatened 50% tariffs on EU goods from June 1. Weak oil prices could hurt energy stocks and add to market's downside.
RTTNews | 1 day ago